Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs	Hemic and Lymphatic Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, nervous system disorder, perceptual disorders, vascular disorder, vascular hemostatic disease	Recruiting	Not applicable	2026-02-03		NCT07384013

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rambam Health Care Campus	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Rambam Health Care Campus	Haifa	Israel	12